Wednesday, 28 June 2017

Vaccines News

  • Vaccine worth $1.3 million spoils in Pakistan

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2015

    Singapore: According to recent reports from the National Health Services of Pakistan, pentavalent vaccine worth nearly $1.3 million has spoiled in a store room in Pakistan. The vaccine, en...Read more

  • Chinese Ebola vaccine found effective in human trials

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2015

    Singapore: An experimental Ebola vaccine candidate developed by the Beijing Institute of Biotechnology and the Tianjin CanSino Biotechnology has been found to be safe in phase I clinical tr...Read more

  • China's vaccine for polio receives approval

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 17 Jan, 2015

    Singapore: The China Food and Drug Administration made an announcement that China's top drug authority has licensed a domestically manufactured polio vaccine for administration. Under the c...Read more

  • Clue to future universal dengue vaccine found

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2013

    Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a clue that has the potential to cripple the ability of the dengue virus to escape the host immune syst...Read more

  • BioSpectrum announces the hits and misses of 2013

    Vaccines |  Analysis | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2014

    Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase in the number of acquisitions and mergers (M&A), it also led to a ...Read more

  • Pfizer inks deal to acquire two vaccines from GSK

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 23 Jun, 2015

    Singapore: To further strengthen its vaccine product pipeline, global drug giant Pfizer has inked a $130 million deal with GlaxoSmithKline Pharmaceuticals to acquire GSK's quadrivalent meni...Read more

  • Takeda revamps vaccine unit operations

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2015

    Singapore: Takeda Pharmaceutical has decided to consolidate its Vaccine Business Unit (VBU) operations by establishing global and regional hubs to leverage the vaccine programs in norovirus...Read more

  • Sanofi's dengue vaccine candidate shows positive results

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2012

    Singapore: Sanofi Pasteur, the vaccines division of Sanofi has published clinical study results of its dengue vaccine candidate in the online publication of The Lancet. The results of the t...Read more

  • Vaccine of the future: Virus-like particles to trigger body's defence

    Vaccines |  Analysis | By Amrita Tejasvi | 0 Comment | 11 Jul, 2012

    Virus-like particles (VLPs) are among the most exciting emerging vaccine technologies for generating effective and long-lasting protection. It is an advanced technology that has a number of...Read more

  • Everyone thought my $1 vaccine shot idea was crazy

    Vaccines |  Opinion | By BioSpectrum Bureau | 0 Comment | 13 May, 2013

    My journey as a scientist and a entrepreneur began with my strong interest in science and how it relates to health and wellness. I am very much concerned about public health, especially neg...Read more

  • Oral cholera vaccine shows promise in clinical trials

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2015

    Singapore: An oral cholera vaccine, Shanchol, developed by Shantha Biotechnics and recommended by WHO has shown promise in first real-life clinical trials by reducing severe cases of choler...Read more

  • Mylan injections found with foreign material

    Vaccines |  Regulatory | By BioSpectrum Bureau | 0 Comment | 27 Apr, 2015

    Singapore: Global pharmaceutical company, Mylan, has run into a trouble for the presence of visible foreign material in injectable products. The company is consequently recalling the affect...Read more

  • India's Tergene Biotech develops vaccine for pneumonia

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2015

    Singapore: Tergene Biotech, an Indian start up, has developed a promising vaccine candidate to combat pneumonia. The vaccine is targeted against specific types of bacteria that cause pneumo...Read more

  • WHO to initiate ebola vaccine trial in Guinea

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 10 Mar, 2015

    Singapore: WHO with the Health Ministry of Guinea, Médecins Sans Frontières (MSF), Epicentre and The Norwegian Institute of Public Health (NIPH), has launched a Phase III trial in Gui...Read more

  • Queensland health officials fear measles outbreak

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2014

    Singapore: With rising measles cases in Queensland, Australian health authorities fear a severe outbreak, as 41 cases have been reported so far in the country. The health officials said tha...Read more

  • Vietnam can now supply vaccines for the world: WHO

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2015

    Singapore: The World Health organization recently certified Vietnam's vaccine management system as internationally standardized declaring that the Southeast Asian nation can now produce vac...Read more

  • Sinovac reports 31% decline in Q1, 2015 revenue

    Vaccines |  Company results | By BioSpectrum Bureau | 0 Comment | 15 May, 2015

    Singapore: China biotech firm, Sinovac Biotech, has reported a decline of 31.6 percent in the first quarter of 2015, clocking the sales at $9.3million, from the previous tear. Sinovac mark...Read more

  • Sinovac to begin clinical trial of varicella vaccine

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 27 Oct, 2015

    Singapore: Sinovac Dalian, subsidiary of China's Sinovac Biotech, has received China Food and Drug Administration approval to begin human clinical trials on its varicella vaccine candidate....Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls